NextCure, Inc. financial data

Symbol
NXTC on Nasdaq
Location
Beltsville, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 548% % -49%
Debt-to-equity 34% % 104%
Return On Equity -133% % -113%
Return On Assets -99% % -84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,679,822 shares -90%
Common Stock, Shares, Outstanding 2,676,110 shares -90%
Entity Public Float $43,600,000 USD -11%
Common Stock, Value, Issued $3,000 USD -89%
Weighted Average Number of Shares Outstanding, Basic 2,676,116 shares 15%
Weighted Average Number of Shares Outstanding, Diluted 2,676,116 shares 15%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $47,025,000 USD 5.9%
General and Administrative Expense $13,289,000 USD -18%
Operating Income (Loss) $60,314,000 USD 4.4%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $58,011,000 USD 0.87%
Earnings Per Share, Basic -4 USD/shares 63%
Earnings Per Share, Diluted -4 USD/shares 63%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,324,000 USD -74%
Assets, Current $32,640,000 USD -59%
Property, Plant and Equipment, Net $3,638,000 USD -41%
Operating Lease, Right-of-Use Asset $2,785,000 USD -18%
Other Assets, Noncurrent $550,000 USD -73%
Assets $39,613,000 USD -56%
Accounts Payable, Current $2,391,000 USD -34%
Employee-related Liabilities, Current $1,753,000 USD 77%
Liabilities, Current $10,995,000 USD 27%
Operating Lease, Liability, Noncurrent $4,411,000 USD -18%
Other Liabilities, Noncurrent $561,000 USD -19%
Liabilities $15,967,000 USD 8.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $17,000 USD -78%
Retained Earnings (Accumulated Deficit) $426,544,000 USD -16%
Stockholders' Equity Attributable to Parent $23,646,000 USD -69%
Liabilities and Equity $39,613,000 USD -56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,994,000 USD -3.1%
Net Cash Provided by (Used in) Financing Activities $1,000 USD
Net Cash Provided by (Used in) Investing Activities $7,094,000 USD -60%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 2,676,110 shares -90%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,900,000 USD -212%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7,324,000 USD -74%
Interest Paid, Excluding Capitalized Interest, Operating Activities $16,000 USD -16%
Deferred Tax Assets, Valuation Allowance $115,309,000 USD 17%
Deferred Tax Assets, Gross $116,372,000 USD 16%
Operating Lease, Liability $5,388,000 USD -12%
Payments to Acquire Property, Plant, and Equipment $37,000 USD -85%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $58,070,000 USD -0.4%
Lessee, Operating Lease, Liability, to be Paid $6,380,000 USD -15%
Property, Plant and Equipment, Gross $28,553,000 USD -2.4%
Operating Lease, Liability, Current $796,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,396,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,355,000 USD 12%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $992,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,438,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $63,647,000 USD 13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,481,000 USD 3%
Operating Lease, Payments $285,000 USD 2.9%
Additional Paid in Capital $450,170,000 USD 1.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $1,063,000 USD -23%
Share-based Payment Arrangement, Expense $4,069,000 USD -40%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%